TY - JOUR
T1 - Hepatic lymphatic vascular system in health and disease
AU - Jeong, Jain
AU - Tanaka, Masatake
AU - Iwakiri, Yasuko
N1 - Funding Information:
This study was supported by NIH grants ( 1R56DK121511 , 1R01AA025342 , R01DK130362 and R01DK117597 ) to YI.
Publisher Copyright:
© 2022 European Association for the Study of the Liver
PY - 2022/7
Y1 - 2022/7
N2 - In recent years, significant advances have been made in the study of lymphatic vessels with the identification of their specific markers and the development of research tools that have accelerated our understanding of their role in tissue homeostasis and disease pathogenesis in many organs. Compared to other organs, the lymphatic system in the liver is understudied despite its obvious importance for hepatic physiology and pathophysiology. In this review, we describe fundamental aspects of the hepatic lymphatic system and its role in a range of liver-related pathological conditions such as portal hypertension, ascites formation, malignant tumours, liver transplantation, congenital liver diseases, non-alcoholic fatty liver disease, and hepatic encephalopathy. The article concludes with a discussion regarding the modulation of lymphangiogenesis as a potential therapeutic strategy for liver diseases.
AB - In recent years, significant advances have been made in the study of lymphatic vessels with the identification of their specific markers and the development of research tools that have accelerated our understanding of their role in tissue homeostasis and disease pathogenesis in many organs. Compared to other organs, the lymphatic system in the liver is understudied despite its obvious importance for hepatic physiology and pathophysiology. In this review, we describe fundamental aspects of the hepatic lymphatic system and its role in a range of liver-related pathological conditions such as portal hypertension, ascites formation, malignant tumours, liver transplantation, congenital liver diseases, non-alcoholic fatty liver disease, and hepatic encephalopathy. The article concludes with a discussion regarding the modulation of lymphangiogenesis as a potential therapeutic strategy for liver diseases.
UR - http://www.scopus.com/inward/record.url?scp=85126296599&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85126296599&partnerID=8YFLogxK
U2 - 10.1016/j.jhep.2022.01.025
DO - 10.1016/j.jhep.2022.01.025
M3 - Review article
C2 - 35157960
AN - SCOPUS:85126296599
VL - 77
SP - 206
EP - 218
JO - Journal of Hepatology
JF - Journal of Hepatology
SN - 0168-8278
IS - 1
ER -